ATE486594T1 - Methode zur behandlung von herzinsuffizienz - Google Patents
Methode zur behandlung von herzinsuffizienzInfo
- Publication number
- ATE486594T1 ATE486594T1 AT01918743T AT01918743T ATE486594T1 AT E486594 T1 ATE486594 T1 AT E486594T1 AT 01918743 T AT01918743 T AT 01918743T AT 01918743 T AT01918743 T AT 01918743T AT E486594 T1 ATE486594 T1 AT E486594T1
- Authority
- AT
- Austria
- Prior art keywords
- heart failure
- treating heart
- chf
- treat
- patient
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 5
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 4
- 230000001684 chronic effect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/533,227 US6288117B1 (en) | 2000-03-23 | 2000-03-23 | Method for treating congestive heart failure |
| PCT/US2001/008418 WO2001070218A1 (en) | 2000-03-23 | 2001-03-16 | Method for treating congestive heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE486594T1 true ATE486594T1 (de) | 2010-11-15 |
Family
ID=24125041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01918743T ATE486594T1 (de) | 2000-03-23 | 2001-03-16 | Methode zur behandlung von herzinsuffizienz |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6288117B1 (de) |
| EP (1) | EP1292292B1 (de) |
| JP (1) | JP2003527420A (de) |
| AT (1) | ATE486594T1 (de) |
| AU (2) | AU2001245785B2 (de) |
| CA (1) | CA2403674C (de) |
| DE (1) | DE60143390D1 (de) |
| IL (2) | IL151878A0 (de) |
| NO (1) | NO20024545L (de) |
| NZ (1) | NZ522088A (de) |
| WO (1) | WO2001070218A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040156893A1 (en) * | 2003-02-11 | 2004-08-12 | Irwin Klein | Method for treating hypothyroidism |
| GB0525461D0 (en) * | 2005-12-15 | 2006-01-25 | Archimedes Dev Ltd | Pharmaceutical compositions |
| US10695309B2 (en) | 2017-03-31 | 2020-06-30 | Western New England University | Sustained-release liothyronine formulations, method of preparation and method of use thereof |
| CN111632155B (zh) * | 2020-06-01 | 2023-01-24 | 西南大学 | 丝胶-钆pH响应性靶向肿瘤核磁共振造影剂的制备方法 |
| CN121868277A (zh) * | 2026-03-18 | 2026-04-17 | 广东医科大学附属第二医院 | Slco5a1在制备用于治疗和/或预防心力衰竭药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3689669A (en) * | 1970-10-09 | 1972-09-05 | Univ Of North Carolina The | Antidepressant method and composition |
| US5158978A (en) | 1990-02-05 | 1992-10-27 | British Technology Group (U.S.A.) | Thyroid hormone treatment of acute cardiovascular compromise |
| DK0550108T3 (da) * | 1991-12-30 | 1999-01-04 | Akzo Nobel Nv | Thyreoaktiv sammensætning med langvarig frigivelse |
-
2000
- 2000-03-23 US US09/533,227 patent/US6288117B1/en not_active Expired - Lifetime
-
2001
- 2001-03-16 IL IL15187801A patent/IL151878A0/xx active IP Right Grant
- 2001-03-16 AT AT01918743T patent/ATE486594T1/de not_active IP Right Cessation
- 2001-03-16 JP JP2001568416A patent/JP2003527420A/ja active Pending
- 2001-03-16 WO PCT/US2001/008418 patent/WO2001070218A1/en not_active Ceased
- 2001-03-16 AU AU2001245785A patent/AU2001245785B2/en not_active Ceased
- 2001-03-16 DE DE60143390T patent/DE60143390D1/de not_active Expired - Lifetime
- 2001-03-16 EP EP01918743A patent/EP1292292B1/de not_active Expired - Lifetime
- 2001-03-16 AU AU4578501A patent/AU4578501A/xx active Pending
- 2001-03-16 CA CA2403674A patent/CA2403674C/en not_active Expired - Fee Related
- 2001-03-16 NZ NZ522088A patent/NZ522088A/en unknown
-
2002
- 2002-09-23 IL IL151878A patent/IL151878A/en not_active IP Right Cessation
- 2002-09-23 NO NO20024545A patent/NO20024545L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001245785B2 (en) | 2005-05-19 |
| IL151878A (en) | 2008-08-07 |
| NZ522088A (en) | 2004-07-30 |
| AU4578501A (en) | 2001-10-03 |
| NO20024545L (no) | 2002-10-29 |
| US6288117B1 (en) | 2001-09-11 |
| IL151878A0 (en) | 2003-04-10 |
| CA2403674C (en) | 2010-06-08 |
| CA2403674A1 (en) | 2001-09-27 |
| DE60143390D1 (de) | 2010-12-16 |
| WO2001070218A1 (en) | 2001-09-27 |
| EP1292292A1 (de) | 2003-03-19 |
| NO20024545D0 (no) | 2002-09-23 |
| JP2003527420A (ja) | 2003-09-16 |
| EP1292292A4 (de) | 2006-02-01 |
| EP1292292B1 (de) | 2010-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
| ATE304849T1 (de) | Cyanomethyl-substituierte thiazolium- und imidazolium-verbindungen und behandlung von erkrankungen im zusammenhang mit proteinalterung | |
| DE60225702D1 (de) | Strontium verbindung zur behandlung von sub-dermalem weichteilschmerz | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| DE60312309D1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
| DE60327557D1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
| ATE421329T1 (de) | Verwendung von aplidine zur behandlung von kardiovaskulären erkrankungen | |
| ATE402699T1 (de) | Verwendung von substituierten pyrazolen zur behandlung von allergien | |
| ATE290384T1 (de) | Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
| ATE480232T1 (de) | Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden | |
| NO20024545D0 (no) | Fremgangsmåte for behandling av kongestiv hjertefeil | |
| EP1056458A4 (de) | Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| ATE453386T1 (de) | Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten | |
| ATE239497T1 (de) | Verwendung von urodilatin zur behandlung chronischer niereninsuffizienz mit nierenrestfunktionen | |
| DE60033569D1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
| ATE315387T1 (de) | Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz | |
| NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| ATE360438T1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
| SE0100873D0 (sv) | Method of treatment | |
| ATE355063T1 (de) | Methode zur behandlung von niereninsuffizienz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |